EUVIMEDEUVIMED entdecken
Crossref

People living with HIV co‐infected with the Kaposi Sarcoma‐associated Herpes Virus have a distinct HIV Tat profile and higher rates of antiretroviral virologic failure, more evident among those with Kaposi's sarcoma

Dalila G Suterio, James R Hunter iD, Simone B Tenore, Sidnei R Pimentel, Juliana Galinskas, Danilo A Dias, Débora C Bellini, Paulo A Ferreira, Ricardo Sobhie Diaz iD

Journal of Medical Virology · 2024

DOI: 10.1002/jmv.29840 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Dalila G Suterio und 8 weiteren Autor:innen. Beteiligte Einrichtung: Retrovirology Laboratory, Infectious Diseases Division, Paulista School of Medicine, Federal University of São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Sarcoma, Kaposi, HIV Infections, Herpesvirus 8, Human, tat Gene Products, Human Immunodeficiency Virus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kaposi sarcoma (KS) is a neoplasm of vascular origin that promotes angiogenesis and the growth of endothelial cells triggered by the Kaposi Sarcoma‐associated Herpes Virus (KSHV). When associated with HIV, KSHV becomes more aggressive and rapidly evolves. The HIV‐1 TAT protein can be essential in developing AIDS‐associated KS by promoting angiogenesis and increasing KSHV replication. Therefore, we evaluated the genetic profile of the first exon of tat gene among groups of people living with HIV (PLHIV) with (case group, n = 36) or without KS, this later with (positive control group, n = 46) and without KSHV infection (negative control group, n = 24); all individuals under antiretroviral therapy. The genetic diversity, the DN/DS ratio, and the genetic entropy of the first exon of tat were higher in the case group, followed by the positive control group, which was higher than the negative control group. The number of tat codons under positive selection was seven in the case group, six in the positive control group, and one in the negative control group. The prevalence of HIV viral loads below the detection limit was equal in the case and positive control groups, which were lower than in the negative control group. The mean CD4+ T cell counts were higher in the negative control group, followed by the positive control group, and followed by the case group. These results emphasize the negative influence of KSHV in antiretroviral treatment, as well as the HIV‐specific TAT profile among PLHIV who developed KS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sarcoma, KaposiHIV InfectionsHerpesvirus 8, Humantat Gene Products, Human Immunodeficiency VirusCoinfectionHumansMaleFemaleAdultMiddle AgedHIV-1Genetic VariationViral LoadAnti-Retroviral AgentsCD4 Lymphocyte Count

Stichwörter der Autor:innen

HIV‐1Kaposi Sarcoma‐associated Herpes VirusKaposi sarcomatat

Substanzen

tat Gene Products, Human Immunodeficiency VirusAnti-Retroviral Agents

Autor:innen und Institutionen

  • Retrovirology Laboratory, Infectious Diseases Division, Paulista School of Medicine, Federal University of São Paulo, São Paulo, Brazil.
  • Assistência, Centro de Referência e Treinamento em DST/AIDS, São Paulo, São Paulo, SP, Brazil.

ORCID-Profile: James R Hunter, Ricardo Sobhie Diaz

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Zitieren

APA

Suterio, D. G., Hunter, J. R., Tenore, S. B., Pimentel, S. R., Galinskas, J., Dias, D. A., Bellini, D. C., Ferreira, P. A., & Diaz, R. S. (2024). People living with HIV co‐infected with the Kaposi Sarcoma‐associated Herpes Virus have a distinct HIV Tat profile and higher rates of antiretroviral virologic failure, more evident among those with Kaposi's sarcoma. Journal of Medical Virology. https://doi.org/10.1002/jmv.29840

Vancouver

Suterio DG, Hunter JR, Tenore SB, Pimentel SR, Galinskas J, Dias DA, et al. People living with HIV co‐infected with the Kaposi Sarcoma‐associated Herpes Virus have a distinct HIV Tat profile and higher rates of antiretroviral virologic failure, more evident among those with Kaposi's sarcoma. Journal of Medical Virology. 2024. doi:10.1002/jmv.29840

BibTeX
@article{Suterio2024,
  author = {Suterio, Dalila G and Hunter, James R and Tenore, Simone B and Pimentel, Sidnei R and Galinskas, Juliana and Dias, Danilo A and Bellini, Débora C and Ferreira, Paulo A and Diaz, Ricardo Sobhie},
  title = {People living with HIV co‐infected with the Kaposi Sarcoma‐associated Herpes Virus have a distinct HIV Tat profile and higher rates of antiretroviral virologic failure, more evident among those with Kaposi's sarcoma},
  journal = {Journal of Medical Virology},
  year = {2024},
  doi = {10.1002/jmv.29840}
}
Kostenlos starten →